NR 607 Psychopharmacology exam with
correct answers
Which |of |the |following |antipsychotics |pose |the |least |cardiometabolic |risk? |- |✔✔Ziprasidone |and |
Ariprazole |are |two |examples |of |antipsychotics |associated |with |lower |cardiometabolic |risk.
A |16-year-old |boy |with |a |history |of |substance |use |disorder |reports |fatigue, |apathy, |and |anhedonia |
almost |every |day |and |his |mother |reports |increasing |irritability |and |raging |behavior. |The |boy |says |he |
smokes |marijuana |daily |just |to |feel |good |and |is |unwilling |to |give |it |up. |The |mother |wants |some |sort |
of |medication |to |help |him |feel |better |so |that |he |stops |smoking |marijuana. |The |PMHNP |agrees |to |
prescribe |fluoxetine |20 |mg |daily. |What |is |the |most |common |side |effect |associated |with |this |
medication? |- |✔✔Nausea
Keenan |is |an |72-year-old |male |admitted |to |the |hospital |with |a |diagnosis |of |delirium. |Medications |
with |anticholinergic |side |effects |are |known |to |cause |delirium. |Which |of |the |following |medications |are
|most |suspect |in |contributing |to |delirium? |- |✔✔Diphenhydramine |and |similar |medications |are |
contraindicated |in |persons |over |65 |given |their |elevated |anticholinergic |activity.
A |patient |who |had |previously |reported |feeling |much |better |on |her |antidepressant |suddenly |says |the
|"drug |seems |to |have |stopped |working. |This |is |known |as: |- |✔✔Tachyphylaxis
One |of |the |most |common |electrolyte |abnormalities |associated |with |the |use |of |psychotropic |
medication |is: |- |✔✔Hyponatremia
A |patient |who |has |been |taking |paroxetine |for |3 |years |wants |to |come |off |due |to |sexual |side |effects. |
He |had |gradually |tried |to |wean |the |dose |on |his |own |but |noticed |a |feelings |of |dizziness, |fatigue, |
headaches, |anxiety, |and |electric-like |shocks |in |his |head. |These |findings |are |most |consistent |with |SSRI |
discontinuation. |What |would |be |a |reasonable |action |for |the |PMHNP |to |take? |- |✔✔Prescribe |the |
patient |fluoxetine |for |1 |week
The |PMHNP |knows |that |the |study |of |how |the |body |absorbs, |distributes, |metabolizes, |and |excretes |a |
medication |is |known |as: |- |✔✔Pharmacokinetics
The |PMHNP |in |the |ED |is |evaluating |a |68-year-old |woman |who |was |recently |diagnosed |with |mild |
cognitive |impairment |and |cannot |remember |the |name |of |the |medication |that |she |has |recently |
started |1 |week |ago. |The |patient |is |complaining |of |increased |heart |rate, |sweating, |and |muscle |spasms |
progressively |worsening |for |the |last |3 |days. |Which |neurotransmitter |is |associated |with |this |adverse |
effect? |- |✔✔Acetylcholine
A |79-year-old |female |with |no |past |psychiatric |history |is |admitted |with |new |onset |auditory |
hallucinations. |The |patient |states |her |most |bothersome |symptom |is |the |voices, |which |have |kept |her |
